MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,129,000 | -71.5% | 911,188 | -29.1% | 0.00% | -100.0% |
| Q1 2017 | $3,957,000 | +495.0% | 1,284,683 | +689.0% | 0.00% | – |
| Q4 2016 | $665,000 | -12.7% | 162,834 | +35.7% | 0.00% | – |
| Q3 2016 | $762,000 | +27.0% | 120,001 | +7.7% | 0.00% | – |
| Q2 2016 | $600,000 | -66.5% | 111,397 | -47.9% | 0.00% | – |
| Q1 2016 | $1,790,000 | +681.7% | 213,889 | +639.7% | 0.00% | – |
| Q4 2015 | $229,000 | -91.1% | 28,917 | -90.4% | 0.00% | -100.0% |
| Q3 2015 | $2,563,000 | -22.4% | 301,174 | +12.8% | 0.00% | 0.0% |
| Q2 2015 | $3,301,000 | -2.3% | 266,984 | -6.1% | 0.00% | 0.0% |
| Q1 2015 | $3,379,000 | -2.9% | 284,417 | -7.7% | 0.00% | 0.0% |
| Q4 2014 | $3,480,000 | +27.9% | 308,047 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $2,720,000 | -64.7% | 309,812 | -70.7% | 0.00% | -66.7% |
| Q2 2014 | $7,715,000 | +83.6% | 1,058,179 | +27.0% | 0.00% | +200.0% |
| Q1 2014 | $4,201,000 | +356.6% | 833,528 | +383.1% | 0.00% | – |
| Q4 2013 | $920,000 | +49.6% | 172,533 | +6.4% | 0.00% | – |
| Q3 2013 | $615,000 | -40.8% | 162,226 | +5.2% | 0.00% | – |
| Q2 2013 | $1,039,000 | +72.0% | 154,211 | +55.4% | 0.00% | – |
| Q4 2012 | $604,000 | +305.4% | 99,255 | +526.7% | 0.00% | – |
| Q3 2012 | $149,000 | – | 15,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|